Bhk Investment Advisors, LLC Eli Lilly & CO Transaction History

Bhk Investment Advisors, LLC

$268 Million
Q3 2024

A detailed history of Bhk Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bhk Investment Advisors, LLC holds 1,586 shares of LLY stock, worth $1.19 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

1,586

Previous 1,558 1.8%

Holding current value

$1.19 Million

Previous $1.41 Million 0.35%

% of portfolio

0.52%

Previous 0.55%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $21,619 - $26,880	28 Added 1.8%	1,586 $1.41 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $327,486 - $438,130	553 Added 55.02%	1,558 $1.21 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $288,329 - $339,902	-549 Reduced 35.33%	1,005 $585,000
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $73,304 - $98,016	-209 Reduced 11.85%	1,554 $728,000
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $147,859 - $173,654	476 Added 36.99%	1,763 $605,000
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $211,258 - $246,158	657 Added 104.29%	1,287 $470,000
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $356,072 - $405,781	-1,201 Reduced 65.59%	630 $204,000
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $1,114 - $1,309	4 Added 0.22%	1,831 $594,000
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $1,173 - $1,458	5 Added 0.27%	1,827 $523,000
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $899 - $1,116	4 Added 0.22%	1,822 $503,000
Q3 2021 Nov 01, 2021	BUY	$221.6 - $272.71 $886 - $1,090	4 Added 0.22%	1,818 $420,000
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $1,624 - $2,101	9 Added 0.5%	1,814 $416,000
Q4 2020 Feb 01, 2021	BUY	$130.46 - $172.63 $652 - $863	5 Added 0.28%	1,805 $305,000
Q3 2020 Oct 22, 2020	SELL	$146.22 - $169.13 $1,754 - $2,029	-12 Reduced 0.66%	1,800 $266,000
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $818 - $985	6 Added 0.33%	1,812 $297,000
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $714 - $884	6 Added 0.33%	1,806 $251,000
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $80,190 - $99,322	-750 Reduced 29.41%	1,800 $237,000
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $126,300 - $147,424	-1,140 Reduced 30.89%	2,550 $282,000
Q1 2019 May 03, 2019	BUY	$111.31 - $131.02 $410,733 - $483,463	3,690 New	3,690 $479,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bhk Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bhk Investment Advisors, LLC with notifications on news.

Account

Bhk Investment Advisors, LLC Eli Lilly & CO Transaction History